Case Report: Opportunities for Electronic Health Record Data to Support Business Functions in the Pharmaceutical Industry - A Case Study from Pfizer, Inc
暂无分享,去创建一个
The Pfizer Healthcare Informatics team conducted a series of guided interviews with 35 Pfizer senior leaders to elicit their understanding, desires, and expectations of how Electronic Health Records (EHR) might be used in the pharmaceutical industry today and/or in the future. The interviews yielded fourteen use case categories comprising 42 specific use cases. The highest priority use cases were "Drug Safety & Surveillance," "Clinical Trial Recruitment," and "Support Regulatory Approval." Fifteen EHR companies were surveyed to assess their functionality against the specified use cases. Self-reported responses from the EHR companies were highest for "Virtual Phase IV Trials" and "Document Management for Clinical Trials." This research identifies preliminary opportunities for EHR products to provide aggregate, blinded data to address the interests of the pharmaceutical industry. However, further collaboration between the stakeholders will be necessary to ensure the full realization of the opportunities for data re-use.
[1] Charles Safran,et al. Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. , 2007, Journal of the American Medical Informatics Association : JAMIA.
[2] Nicholas C. Ide,et al. Trial Registration at ClinicalTrials.gov between May and October 2005. , 2005, The New England journal of medicine.